Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/07/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 485 publications

IgA Nephropathy: An Overview of the Clinical Trials.

IgA Nephropathy: An Overview of the Clinical Trials.

Journal: Kidney medicine
Published: October 06, 2025

Cancer-Induced Cardiac Dysfunction: Mechanisms, Diagnostics, and Emerging Therapeutics in the Era of Onco-Cardiology.

Cancer-Induced Cardiac Dysfunction: Mechanisms, Diagnostics, and Emerging Therapeutics in the Era of Onco-Cardiology.

Journal: Cancers
Published: September 10, 2025

From RAAS blockade to regenerative medicine: evolving treatment strategies in Alport syndrome.

From RAAS blockade to regenerative medicine: evolving treatment strategies in Alport syndrome.

Journal: Pediatric nephrology (Berlin, Germany)
Published: June 24, 2025

Atrasentan: First Approval.

Atrasentan: First Approval.

Journal: Drugs
Published: June 23, 2025

Corrigendum to "Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy" [Volume 10, Issue 1, January 2025, Pages 217-226].

Corrigendum to "Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy" [Volume 10, Issue 1, January 2025, Pages 217-226].

Journal: Kidney international reports
Published: April 30, 2025

Efficacy and safety of endothelin A receptor antagonists in IgA nephropathy: a systematic review and meta-analysis.

Efficacy and safety of endothelin A receptor antagonists in IgA nephropathy: a systematic review and meta-analysis.

Journal: Clinical kidney journal
Published: January 17, 2025

ALIGNing the treatment of IgA nephropathy: Reducing proteinuria with endothelin A receptor inhibition.

ALIGNing the treatment of IgA nephropathy: Reducing proteinuria with endothelin A receptor inhibition.

Journal: Med (New York, N.Y.)
Published: November 19, 2024

Endothelin receptor antagonists in chronic kidney disease.

Endothelin receptor antagonists in chronic kidney disease.

Journal: Nature reviews. Nephrology
Published: October 30, 2024

Atrasentan in Patients with IgA Nephropathy.

Atrasentan in Patients with IgA Nephropathy.

Journal: The New England journal of medicine
Published: October 26, 2024

14,15-epoxyeicosatrienoic acid analog augments hypotensive effect of an endothelin-A receptor blocker antrasentan and prevents oedema and organ hypertrophy in spontaneously hypertensive rats.

14,15-epoxyeicosatrienoic acid analog augments hypotensive effect of an endothelin-A receptor blocker antrasentan and prevents oedema and organ hypertrophy in spontaneously hypertensive rats.

Journal: Journal of physiology and pharmacology : an official journal of the Polish Physiological Society
Published: October 01, 2024

Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy.

Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy.

Journal: Kidney international reports
Published: July 15, 2024

Sex differences in response to the endothelin receptor antagonist atrasentan in individuals with type 2 diabetes and chronic kidney disease: a post hoc analysis of the SONAR trial.

Sex differences in response to the endothelin receptor antagonist atrasentan in individuals with type 2 diabetes and chronic kidney disease: a post hoc analysis of the SONAR trial.

Journal: Diabetologia
Published: July 11, 2024
Showing 1-12 of 485

Last Updated: 01/07/2026